In the News
Are we winning the war on AIDS?
New HIV infection rates are falling, and treatments are improving. But do we have the political will to end HIV/AIDS?
Dallas Voice talked with Bryan King of North Texas Infectious Disease Consultants.
Lenacapavir for HIV-1 — Potential Promise of a Long-Acting Antiretroviral Drug
The Research Department at North Texas ID Consultants is proud to be listed in the New England Journal of Medicine as collaborators with this new, and exciting long acting antiretrovirals for the treatment of HIV. We are currently enrolling in other studies using long acting medications for the treatment of HIV. If you are interested in one of our clinical trials you can contact the research department through our website at www.infectiousdiseases.com under the research section.
You will need the Adobe Reader to view and print these documents. 